- Global Markets
- Global Leaders
- Global Technology
- Global Ideas
- Investing With a Global Vision
Eyestart is an accelerator for early stage biotechnology, medical device, and life sciences projects. We grow multiple ophthalmic and other start-ups that enhance strategic and random encounters and nurture synergistic opportunities.
1991 – Toby Chan committed to becoming a doctor.
1994- Dr. Richard Weinstein graduated from University of Ottawa Medical School.
1995 – Dr. Richard Weinstein started residency in Puerto Rico.
1999 - Jaspreet Rayat committed to making the world a better place.
2000- Dr Richard Weinstein completed residency in ophthalmology at UMDNJ.
2001 – Dr. Richard Weinstein invested in gold.
2002 – Dr. Richard Weinstein began ophthalmology practice in Kitchener-Waterloo.
2002 – Toby Chan completed Bachelor of Science with High Distinction at University of Toronto.
2004 – Dr. Richard Weinstein volunteered in Guyana.
2005 – Toby Chan did his first international Ophthalmology elective in Beijing, China.
2006 – Toby Chan completed M.D. at University of Ottawa.
2007/8 – Dr Richard Weinstein co-founded Ocular Health Centre.
2008 - Dr Richard Weinstein co-founded Ocular Health Network.
2008 - Jaspreet Rayat completed Bachelor of Health Sciences (summa cum laude) at McMaster University.
2010 – Dr. Toby Chan did his second international Ophthalmology elective at the Hong Kong Eye Hospital.
2010 – Dr. Toby Chan founded the first Canadian Surgical Technologies and Advanced Robotics (CSTAR) Oculoplastics Course at the University of Western Ontario as an Ophthalmology Resident.
2010 – Dr. Toby Chan won the Resident Research Day Award for the third consecutive year at the Ophthalmology Research Day at University of Western Ontario.
Residency and Fellowship
2011 - Dr Jaspreet Rayat presented his macular hole study at the European Union Retina Society meeting in London, UK.
2011 – Dr. Toby Chan presented his own surgical video for the first time at the Toronto Cataract Conference and won the Best Resident Surgical Video Award.
2011 – Dr. Toby Chan completed Ophthalmology residency at University of Western Ontario and won the E.A. Baker Fellowship from the Canadian National Institute for the Blind.
2012 – Dr. Toby Chan completed fellowship in Glaucoma and Advanced Anterior Segment Surgery at University of Toronto.
2012 – Dr. Toby Chan joined the Ocular Health Centre in Kitchener, Ontario.
2012 – Dr. Jaspreet Rayat completed his MD from Queens University.
2013 – Dr. Jaspreet Rayat presented his cataract surgery and patient retention study at the Canadian Ophthalmology Society meeting in Montreal, Quebec.
2013 – Dr. Toby Chan joined the Ophthalmology faculty at McMaster University.
2015 - Dr Jaspreet Rayat presented his study on Cogan type congenital oculomotor apraxia at the Canadian Ophthalmology Society meeting in Victoria, British Columbia.
2016 - Dr Jaspreet Rayat presented his CAN-PAT study at the Canadian Ophthalmology Society meeting in Ottawa, Ontario.
Ocular Health Center
2017 - Dr. Jaspreet Rayat completed his ophthalmology residency at University of Alberta.
2017 – Dr Jaspreet Rayat joined the faculty of University of Alberta as clinical lecturer.
2017 – Dr. Toby Chan became the first eye surgeon in Southwestern Ontario to offer micropulse cyclophotocoagulation for treatment of glaucoma.
2018 – Dr. Toby Chan chaired the Canadian Glaucoma Society Annual Meeting.
2019 – Dr. Jaspreet Rayat joined the Ocular Health Centre in Kitchener, Ontario.
2019 – Drs. Chan, Rayat, and Weinstein merged their medical practices.
2019 – Dr. Toby Chan completed a two-year Emerging Leaders Program (as one of 20 selected young ophthalmologists in Canada) co-developed by Johnson & Johnson and University of Toronto Rotman School of Business.
2020 – Dr Rayat joined the faculty of medicine at McMaster University as adjunct assistant professor.
2020 – Dr. Toby Chan chaired the Glaucoma Section of the Canadian Ophthalmology Society Annual Meeting.
2020 – Dr. Toby Chan became Co-Division Lead of Ophthalmology at St. Mary’s General Hospital and Grand River Hospital in Kitchener, Ontario, Canada.
2021 – EyeStart launched at Digital.Davos.2021.
2021 – Dr. Toby Chan became the first eye surgeon in Southwestern Ontario to perform cataract surgery with a novel intraocular lens (IOL) using an automated, disposable, preloaded IOL delivery system.
years 1991 to 1999
years 2000 to 2005
years 2006 to 2010
years 2011 to 2012
years 2013 to 2016
years 2017 to 2019
years 2020 to 2021
Meet The Team
What we do
We tackle business problems with intelligence. We use cutting-edge tech and cutting-edge thinking to bring ideas to life and impact globally.
We take the best in class ideas at early stages and work with innovators to develop solutions to problems, both big and small.
We bring together the best and brightest minds across our vast networks to transition intellectual property into real business plans thereby fueling economic growth and exponential value.
Working with traditional venture capital and non-traditional sources, we develop and execute strategies to secure the resources to turn ideas into next-generation technologies.
We take innovations at the start-up level and turn them into revenue-generating ventures, increasing both scale and value in the medical, biotechnology and life science spaces.
events and media
Prof. James Cooper at the Gonzaga University School Of Law Human Rights Conference
Gonzo Lawyering: A Lifetime of Disruption
Dr. Richard Weinstein at Digital Davos 2022
Dr. Jaspreet Rayat at Digital Davos 2022
LEARNING BY DOING - Prof. James Cooper
EyeStart 2021 Webinar Series
Traditional Knowledge in Taiwan
Understanding the World of Cryptocurrency
EyeStart in the news
Dr. Rayat completing the first implant of the Alcon Vivity PCIOL at St.Mary's General Hospital.
EyeStart at Digital Davos 2021
Dr. Richard Weinstein, Digital Davos 2021,
Investments Success Stories of 2020
Counselling with Dr. Toby Chan
Dr. Toby Chan, Digital Davos 2021 presentation
Dr. Richard Weinstein, Digital Davos 2021
Ethics and Technologies in Developing Countries
Dr. Jaspreet Rayat Interview
Professor James Cooper at the San Diego Blockchain Forum
Leading vision-enhancement platform, eSight, today announces a new research and development partnership with the Ocular Health Centre, one of Ontario’s top multi-doctor ophthalmology practices, and the cofounders of medical device incubator, EyeStart, Inc.
The partnership with Dr. Jaspreet Rayat, Dr. Richard Weinstein and Dr. Toby Chan in Kitchener-Waterloo will focus on direct patient feedback in a study that will shape eSight’s future. eSight Chief Technology Officer Charles Lim, Senior Product Manager Khurram Farooq and research scientist Dr. Elena Marenny are leading the project, which will involve a stepwise research study during the developmental process.
illumiSonics Names EyeStart Co-Founders As Scientific Advisors
Drs. Toby Chan, Jaspreet Rayat and Richard Weinstein have joined illumiSonics, a promising Canadian optical imaging company, as scientific advisors. “We are excited with this new partnership that further strengthens illumiSonics’ patented Photoacoustic Remote Sensing (PARS®) technology as we look deeper into the human body,” said Rocky Ganske, President and Chief Executive Officer of illumiSonics.
For Dr. Jaspreet Rayat, one of the co-founders of EyeStart, a new incubator in the medtech space based in Kitchener, Ontario, “illumiSonics is a company striving to help physicians treat patients before they develop disease. We see a lot of potential upside with PARS in eyecare.”
Press release here
WE CREATE BEST OPPORTUNITIES FOR YOUR IDEAS.
EyeStart is serious about its role in thought leadership. We regularly publish our innovative ideas about the intersection of investment, medicine, technology, and regulation in academic journals and in the media. Here are a few examples of our work:
In the inevitable scenario of a new endemic virus, hopefully we can utilise a more balanced, evidence-based approach going forward.
While some countries have mandated Covid-19 vaccines for children and adolescents, with approval now being sought for 6-month-olds, other jurisdictions have pursued a different approach.
Touchless technology could enable early detection and treatment of eye diseases that cause blindness
Dr. Richard Weinstein, EyeStart Co-founder is quoted in the University of Waterloo Website News.
“PARS may move us beyond the current gold standard in ophthalmological imaging,” said Dr. Richard Weinstein.
The EyeStart team publishes an opinion piece in the Hill (thehill.com) on telemedicine. Should we be thinking of unintended consequences?
Click here to read our thoughts from a leading journalism platform in the United States. Doctors Toby Chan, Jaspreet Rayat and Richard Weinstein joined with Professor James Cooper to write this. The authors are Canadian but our prescriptions for the future of telemedicine are global.
We will be announcing our webinar on telemedicine in a few days. Save the Date: May 27, 6 p.m. EST
Come back here for the registration information. There is no registration fee for the webinar.
While we are all applauding the roll-out of the various vaccines for Covid-19, it is time to take stock of well, stocks. The supply of the vaccine has been sparse - not just in Canada, but around the world. Stock prices for the few companies which have been able to rush through the emergency approvals for their respective vaccines have soared while the pandemic has killed millions, put hundreds of millions out of work, and reset all our lives.
Go here for the complete article
BY Prof. James Cooper
This past year, the People’s Bank of China has rolled out its Digital Currency Electronic Payment (DCEP) initiative with a major pilot implementation project underway. Several lottery efforts to promote the DCEP were undertaken and a business-friendly, blockchain-services network was added.
By Dr. Jaspreet Rayat
New research from the University of Alberta's Faculty of Medicine & Dentistry is showing less is more when it comes to the treatment of optic disc pits-a rare eye condition.
By James M. Cooper and Bashar Malkawi
Millions of people will be infected with COVID-19 and require treatment, and hundreds of millions more need to be tested. And more than 7 billion people may need to be vaccinated once we find a way to protect humanity from this horrid pandemic. The niceties of IP law should not get in the way of our countries fighting it.
By James Cooper and Tokio Matsuzaki
Telemedicine provides convenience and cost-effective medical care. Recently, it has become more comprehensive, expanding to acute and chronic conditions, and migrating from hospital to home and mobile devices.
An atypical case of bilateral posterior scleritis in a patient with chronic lymphocytic leukemia
By Dr. Toby Chan and Dr. Alexander K. Soon
Canadian Journal of Ophthalmology
Anatomical and visual outcomes of macular hole surgery with short-duration 3-day face-down positioning
By Dr. David R P Almeida, Dr. Jonathon Wong, Dr. Michel Belliveau, Dr. Jaspreet Rayat, Dr. Jeffrey Gale
Canadian Journal of Ophthalmology
Factors affecting postoperative stereopsis in acquired nonaccommodative esotropia
By Toby Y.B. Chan, MD, FRCSC - Alex J. Mao, MD, OD, MPH, Jacqueline R. Piggott, MD, Inas Makar, MB BCh, FRCS (ED)
Canadian Journal of Ophthalmology
Long-term outcomes for Optic Disk Pit Maculopathy after Vitrectom
By Rayat, Jaspreet S. MD; Rudnisky, Christopher J. MD, MPH, FRCSC; Waite, Chris MD, FRCSC, BSc; Huang, Paul BSc; Sheidow, Tom G. MD, FRCSC; Kherani, Amin MD, FRCSC; Tennant, Matthew T. S. BA, MD, FRCSC, ABO
RETINA® - The Journal of Retinal and Vitreous Deseases
Anatomical and visual outcomes of macular hole surgery with short-duration 3-day face-down positioning
By David R P Almeida, Jonathon Wong, Michel Belliveau, Jaspreet Rayat, Jeffrey Gale
National Center for Biotechnology Information
Factors affecting postoperative stereopsis in acquired nonaccommodative esotropia
By Toby Y.B. Chan, MD, FRCSC, Alex J. Mao, MD, OD, MPH, Jacqueline R. Piggott, MD, Inas Makar, MB BCh, FRCS (ED)
Canadian Journal of Ophthalmology
Optic nerve gray crescent can confound neuroretinal rim interpretation: review of the literature
By Sourabh Arora, Jaspreet Rayat, Karim F Damji
National Center for Biotechnology Information
Alternating Hypotropia with Pseudoptosis: A New Phenotype of Congenital Cranial Dysinnervation Disorder
By Fady Sedarousa, Toby Y.B. Chan, Inas Makarc
Case Report Ophthalmology
Burden and Depression among Caregivers of Visually Impaired Patients in a Canadian Population
By Zainab Khan, Puneet S. Braich, Karim Rahim, Jaspreet S. Rayat, Lin Xing, Munir Iqbal, Karim Mohamed, Sanjay Sharma, and David Almeida
US National Library of Medicine
National Institutes of Health
Needs assessment of ophthalmology education for primary care physicians in training: comparison with the International Council of Ophthalmology recommendations
By Toby YB Chan, Amandeep S Rai, Edwin Lee, Jordan T Glicksman, Cindy ML Hutnik1
Case Report Ophthalmology
WEBINAR SERIES 2021
Telemedicine and Teleteaching in the Age of COVID
Webinar 1: Challenges Today - THURSDAY, 27 May, 2021, 6:00PM EST
Webinar 2: Opportunities Tomorrow - THURSDAY, 10 June, 2021, 6:00PM EST
Webinar 1 - 27 May 2021 Video
Webinar 2 - 10 June 2021 Video
Thank you so much for joining us for our webinars on May 27 and June 10, 2021, events that EyeStart convened to learn more about telemedicine and teleteaching in the age of COVID 19. With experts from around the world, these two webinars explored the challenges and opportunities concerning medical care and medical education and the role that regulation may play.
Co-sponsored by the Michael G DeGroote School of Medicine at McMaster University, the David Geffen School of Medicine at University of California, Los Angeles, the University of California, San Diego School of Medicine, California Western School of Law in San Diego and the Ocular Health Network, the webinars brought participants from Hong Kong, Taiwan, Canada, the United States and Latin America.
It was a great learning event for everyone and we are excited about our future educational programming. We will continue to provide a learning platform so that health practitioners, the investment community, students, regulators and life science innovators can interact. We will be in touch soon about our next webinar – one dedicated to investment in the MedTech field that we hope to coordinate in September 2021.
Please send them to your colleagues and friends if they have an interest in the topics we discussed. Dr. Toby Chan & Dr. Jaspreet Rayat Co-founders, EyeStart
Dr. jaspreet Rayat
Assistant Clinical Professor (Adjunct), Michael G. DeGroote School of Medicine, McMaster University, Waterloo Regional Campus, Ontario, Canada
Dr. Jaspreet S. Rayat is an assistant clinical professor (adjunct) of ophthalmology at the McMaster University, he completed his Bachelor of Health Sciences from McMaster University graduating with highest distinction. He then obtained his Doctor of Medicine at Queen’s University and pursued his Ophthalmology training at the University of Alberta, and had the honor of serving as Chief Resident.
During his training, Dr. Rayat performed hundreds of intraocular surgeries with the most modern technology. He has also published numerous research articles in renowned journals, interviewed by media outlets for his innovation and invited to conferences around the world to present his findings.
He has been the recipient of multiple research awards including the top 5 resident ophthalmic researchers in Canada by the Novartis Vision Fund, NSERC research grants and the prestigious Reg Martiniuk prize for first place for his research at the University of Alberta. As an Eye physician and Surgeon, he has the expertise to manage a comprehensive range of ocular conditions including cataract surgery, glaucoma lasers, and pterygium surgery. He also performs anti-VEGF injections for macular degeneration, diabetic retinopathy and retinal vein occlusions. He is fluent in English, Punjabi and Hindi.
1. Capsular block syndrome 20 years post-cataract surgery.Plemel DJA, Benson MD, Rayat JS, Greve MDJ, Tennant MTS.Can J Ophthalmol. 2018 Dec;53(6):e222-e224. doi: 10.1016/j.jcjo.2018.02.009. Epub 2018 Apr 5.PMID: 30502997 No abstract available. 2. The application of a "6S Lean" initiative to improve workflow for emergency eye examination rooms.Nazarali S, Rayat J, Salmonson H, Moss T, Mathura P, Damji KF.Can J Ophthalmol. 2017 Oct;52(5):435-440. doi: 10.1016/j.jcjo.2017.02.017. Epub 2017 Apr 15.PMID: 28985800 3. Phaco-trabectome versus phaco-iStent in patients with open-angle glaucoma.Kurji K, Rudnisky CJ, Rayat JS, Arora S, Sandhu S, Damji KF, Dorey MW.Can J Ophthalmol. 2017 Feb;52(1):99-106. doi: 10.1016/j.jcjo.2016.06.018. Epub 2016 Sep 7.PMID: 28237158 4. Canadian preference and trends survey results for anti-VEGF treatment of macular edema.Rayat JS, Grewal PS, Whelan J, Tennant MT, Choudhry N.Can J Ophthalmol. 2016 Jun;51(3):233-7. doi: 10.1016/j.jcjo.2015.10.014.PMID: 27316276 No abstract available. 5. Burden and Depression among Caregivers of Visually Impaired Patients in a Canadian Population.Khan Z, Braich PS, Rahim K, Rayat JS, Xing L, Iqbal M, Mohamed K, Sharma S, Almeida D.Adv Med. 2016;2016:4683427. doi: 10.1155/2016/4683427. Epub 2016 Mar 8.PMID: 27051859 Free PMC article. 6. LONG-TERM OUTCOMES FOR OPTIC DISK PIT MACULOPATHY AFTER VITRECTOMY.Rayat JS, Rudnisky CJ, Waite C, Huang P, Sheidow TG, Kherani A, Tennant MT.Retina. 2015 Oct;35(10):2011-7. doi: 10.1097/IAE.0000000000000576.PMID: 25923958 7. Optic nerve gray crescent can confound neuroretinal rim interpretation: review of the literature.Arora S, Rayat J, Damji KF.Can J Ophthalmol. 2014 Jun;49(3):238-42. doi: 10.1016/j.jcjo.2014.02.004.PMID: 24862768 Review. 8. Visual function and vision-related quality of life after macular hole surgery with short-duration, 3-day face-down positioning.Rayat J, Almeida DR, Belliveau M, Wong J, Gale J.Can J Ophthalmol. 2011 Oct;46(5):399-402. doi: 10.1016/j.jcjo.2011.07.015. Epub 2011 Aug 4.PMID: 21995981
Dr. Howard Taras
Professor of Pediatric Medicine, University of California, San Diego, U.S.A.
San Diego Unified School District Physician
McMaster University School of Medicine Alumnus
Dr. Howard Taras graduated with a BSc in Honours Biochemistry from McMaster University in 1978. He was in the 10th graduating class of McMaster University’s School of Medicine (later renamed DeGroote School of Medicine), His was the first graduating medical class with a majority female population.
After a Pediatrics residency at Hospital for Sick Children in Toronto, Taras completed a fellowship in Community Pediatrics at University of California-San Diego, specializing in School Health. He was recruited to the faculty of UCSD’s Pediatrics Department afterwards, where he remains to this day.
In addition to practicing and teaching general pediatrics, Taras developed health-to-community joint endeavors such as: initiating continuity clinic resident placement into community clinics and practices; recruiting schools to help enlist low-income children into health insurance programs; linking schools with oral health prevention programs; assisting schools with safe placement of children with medically fragile conditions, and training law students (California Western School of Law) to better understand and collaborate with health and other professionals .
As past director of Community Engagement Division of UCSD’s Clinical Translational Research Institute, Taras bridged community members’ health and research priorities with those of basic and clinical researchers.
Several international assignments, numerous scientific publications, and a smattering of awards highlight his career thus far. Currently Taras provides medical consultation services to school districts across California
Panelists webinar 1
Dr. Larry Friedman
Primary Care Physician
Associate Dean, Clinical Affairs, International Professor of Clinical Medicine and Pediatrics University of California, San Diego School of Medicine, U.S.A.
Dr. Friedman is the Associate Dean for Clinical Affairs, Professor of Pediatrics and Medicine and CEO of the International Clinical Programs at UC San Diego Health System (UCSDHS) and School of Medicine. As the CEO of International Clinical Programs Dr. Friedman works closely with foreign embassies, health ministries and insurance companies to assure individuals worldwide have access to the clinical expertise available at UC San Diego Health System.
As a Professor in the School of Medicine, Dr. Friedman is involved with training the next generation of physicians. He works closely with physicians locally and around the world to educate on a variety of topics, most recently related to IT and the application of Telemedicine. Dr. Friedman co-founded the UC San Diego Telemedicine program and has guided its growth throughout California and into several international locations.
He also serves as the physician champion for Telemedicine collaboration between all six University of California health sciences campuses. He was also one of the early architects of the UCSDHS electronic health record strategy, data warehouse and health information exchange.
His other responsibilities include measurement and improvement of clinical quality in the ambulatory and community setting and has served on several national Committees focused on Quality including the National Quality Forum, Agency for Health Care Research and Quality, University HealthCare Consortium. He is the past UC San Diego Division Chief of Pediatrics and Adolescent Medicine as well as the Medical Director of Ambulatory Quality and Safety.
Dr. Friedman has authored more than 60 publications and is a reviewer for several peer-reviewed medical publications. Dr. Friedman is also the recent past President of the Board of Trustees of the Museum of Photographic Arts in San Diego and is currently a member of the Board at the La Jolla Playhouse.
Dr. Barbara Enry
Medical Liaison for International Programs
ASCRS Foundation, Fairfax, Virginia, U.S.A.
Barbara C. Erny, MD is a board-certified ophthalmologist who practiced at the Palo Alto Medical Foundation for over 25 years. Graduating Phi Beta Kappa and cum laude in Neurobiology from Cornell University, she then obtained her MD from Stanford University School of Medicine, with Honors in Research.
Dr. Erny practiced ophthalmology for 26 years with Sutter Health. During this time, she was awarded the Santa Clara County Medical Association Community Service Award for her volunteer work in developing countries. Her international service spans over 25 years, from providing basic medical care in villages to teaching eye surgery in medical schools. Countries served include India, Bhutan, Peru, Guatemala, Ethiopia, and Rwanda.
Currently, Dr. Erny is drawing upon her skills and experience to serve as the American Society of Cataract and Refractive Surgery (ASCRS) Foundation Medical Liaison for International Programs. Her mission is to coordinate efforts of organizations committed to ophthalmic education and eliminating curable cataract blindness in the developing world. She works on site with residency directors and ophthalmic educators in developing countries and teaches surgical techniques. At home, her endeavors include being chairman of the selection committee for the annual Young Eye Surgeons’ International Service Grant, and she advises the winners on their virtual and in-person global health projects.
A strong advocate for advancing environmental health, Dr. Erny is a member of the Climate Action Working Group of the International Agency for the Prevention of Blindness. She also serves on the Physicians for Social Responsibility Environmental Health Committee and the Steering Committee for the Medical Societies Consortium on Climate and Health. Her position on the editorial board of the new Journal of Climate Change and Health keeps her abreast of the latest studies from around the world. Dr. Erny’s greatest satisfaction at home comes from mentoring medical students who are advocating for and developing climate change and health curricula.
Dr. Mohamed Alarakhia
Managing Director, The eHealth Centre of Excellence
Faculty Digital Health Lead, Michael G. DeGroote School of Medicine, McMaster University, Waterloo Regional Campus, Canada
Dr. Mohamed Alarakhia is:
a Family Physician at the Centre for Family Medicine Family Health Team
the Managing Director of the eHealth Centre of Excellence
the Chief Clinical Information Officer for Ontario Health, West Region.
Assistant Clinical Professor at McMaster University
Adjunct Professor, University of Waterloo
Faculty Digital Health Lead at McMaster University, Michael G. DeGroote School of Medicine (Waterloo Campus)
Dr. Alarakhia was awarded the Digital Health Executive of the Year Award in 2019 and the 2018 College of Family Physicians of Canada Award of Excellence.
The eHealth Centre of Excellence won the Patient Care Innovation Team Award at the 2019 Canadian Health Informatics Awards and a 2019 Ingenious Award from Information Technology Association of Canada.
Dr. Toby Chan
Assistant Clinical Professor (Adjunct), Michael G. DeGroote School of Medicine,
McMaster University, Waterloo Regional Campus, Ontario, Canada
Dr. Chan is Co-Division Head of Ophthalmology for both St. Mary’s General Hospital and Grand River Hospital in Kitchener.
He is the first fellowship-trained glaucoma and anterior segment surgeon in the Kitchener-Waterloo region, and is an assistant clinical professor (adjunct) of ophthalmology at the McMaster University. He received his medical degree at the University of Ottawa and completed residency at the University of Western Ontario. During residency, he received the Best Resident Research Project Award for three consecutive years at UWO, Best Glaucoma Research Proposal Award from the Canadian Glaucoma Society, and achieved third place for the Canadian Ophthalmological Society Award for Excellence in Research.
He completed a fellowship in Glaucoma and Advanced Anterior Segment Surgery at the University of Toronto. He is trained and experienced in advanced cataract and glaucoma procedures including femtosecond laser-assisted cataract surgery and minimally invasive glaucoma surgery. Dr. Chan served as chair of the planning committee for the Canadian Glaucoma Society annual meeting in 2018, and was co-director of the glaucoma skills transfer course at the Canadian Ophthalmological Society annual meeting in 2017 and at the International Congress on Glaucoma Surgery in 2018. He is co-chairing the glaucoma section at the Canadian Ophthalmological Society annual meeting in 2019 and 2020.
In addition to authoring 5 textbook chapters and 13 journal articles, he has given over 50 presentations in national and international conferences. His current research focus is in novel glaucoma treatment options, anterior segment reconstruction, and use of technologies in improving the patient experience and medical education. Dr. Chan is fluent in English, Cantonese and Mandarin.
1. Alternating Hypotropia with Pseudoptosis: A New Phenotype of Congenital Cranial Dysinnervation Disorder.Sedarous F, Chan TYB, Makar I.Case Rep Ophthalmol. 2018 Feb 1;9(1):96-101. doi: 10.1159/000485832. eCollection 2018 Jan-Apr.PMID: 29643789 Free PMC article. 2. An atypical case of bilateral posterior scleritis in a patient with chronic lymphocytic leukemia.Soon AK, Chan TY.Can J Ophthalmol. 2015 Aug;50(4):e60-3. doi: 10.1016/j.jcjo.2015.05.009.PMID: 26257236 No abstract available. 3. Transscleral suture fixation following recurrent toric intraocular lens rotation.Arjmand P, Chan TY, Ahmed II.J Cataract Refract Surg. 2015 May;41(5):912-7. doi: 10.1016/j.jcrs.2015.04.008. Epub 2015 May 6.PMID: 25956713 4. Factors affecting postoperative stereopsis in acquired nonaccommodative esotropia.Chan TY, Mao AJ, Piggott JR, Makar I.Can J Ophthalmol. 2012 Dec;47(6):479-83. doi: 10.1016/j.jcjo.2012.09.005.PMID: 23217499 5. Needs assessment of ophthalmology education for primary care physicians in training: comparison with the International Council of Ophthalmology recommendations.Chan TY, Rai AS, Lee E, Glicksman JT, Hutnik CM.Clin Ophthalmol. 2011;5:311-9. doi: 10.2147/OPTH.S17567. Epub 2011 Mar 3.PMID: 21468339 Free PMC article. 6. Vitritis and retinal vasculitis as presenting signs of monoclonal gammopathy of unknown significance with progression to multiple myeloma.Chan TY, Hodge WG.Can J Ophthalmol. 2010 Feb;45(1):82-3. doi: 10.3129/i09-182.PMID: 20130722 No abstract available.
Panelists webinar 2
Dr. Piyush P. Nayyar
Assistant Clinical Professor, David Geffen School of Medicine, University of California Los Angeles, U.S.A.
Internal Medicine Cedars-Sinai Medical Center, and California Rehabilitation Institute, Los Angeles, U.S.A.
Dr. Pete Nayyar is an internal medicine physician who practices at UCLA Health – Santa Monica Medical Center, Cedars-Sinai Medical Center, and California Rehabilitation Institute. He is board certified in internal medicine and passionate about the therapeutic relationship between practitioner and patient. He focuses on evidence-based, integrative medicine, with an emphasis on the broader concepts of health promotion, early diagnosis, and prevention of complications. He currently serves as Assistant Clinical Professor at the David Geffen School of Medicine at UCLA and is also a member of the UCLA Joint Ethics Committee.
Dr. Nayyar received his medical degree from the State University of New York where he graduated Cum Laude and was awarded the prestigious Harold A. Lyons Award for Excellence in Clinical Medicine 2013, for the top graduating student in medicine. He completed his internship and residency in internal medicine at Cedars-Sinai Medical Center/UCLA VA in Los Angeles. He was awarded the Paul Rubenstein Award for Excellence in Resident Research across all specialties in 2016. His research in cardiovascular interventions, which won him the Paul Rubenstein Award, was published in the Journal of the American College of Cardiology.
Dr. Nayyar recently earned his Master of Business Administration degree from the UCLA Anderson School of Management, where he was awarded the Merit Fellowship and the Net Impact Consulting Award. Additionally, Dr. Nayyar is pursuing a degree in integrative medicine and was the recipient of the Andrew Weil Center for Integrative Medicine Fellowship Scholarship and the Training New Trainers Primary Care Psychiatry Fellowship Scholarship at the University of California. He completed his undergraduate degree in Economics from Cornell University, where he graduated Phi Beta Kappa and published in "The Economic Naturalist."
Prior to joining UCLA Health in 2016, Dr. Nayyar worked at the Food and Drug Administration and as a physician for the City of Los Angeles and Los Angeles Police Department. He was also a consultant for PhytoMed, a New Zealand based herbal medicine company for naturopathic physicians.
Dr. Nayyar is a member of the American College of Physicians, California Medical Association, Phi Beta Kappa, Golden Key, Omnicron Delta Epsilon, and Tau Kappa Epsilon, among other organizations. He is an avid student of yoga and meditation, and in particular, Tibetan Buddhism. His interests include philosophy, mind-body medicine, psychology, functional medicine, psychotherapy (ISTDP) and Ayurveda. He also loves traveling, classic rock, diving and baseball.
1. Optimal P2Y12 Inhibitor in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: A Network Meta-Analysis.Rafique AM, Nayyar P, Wang TY, Mehran R, Baber U, Berger PB, Tobis J, Currier J, Dave RH, Henry TD.JACC Cardiovasc Interv. 2016 May 23;9(10):1036-46. doi: 10.1016/j.jcin.2016.02.013.PMID: 27198684 2. Bugs, genes, fatty acids, and serotonin: Unraveling inflammatory bowel disease?Kaunitz J, Nayyar P.F1000Res. 2015 Oct 27;4:F1000 Faculty Rev-1146. doi: 10.12688/f1000research.6456.1. eCollection 2015.PMID: 27508055 Free PMC article. Review.
Prof. James M. Cooper
Associate Dean, Experiential Learning; Director, International Legal Studies
California Western School of Law, U.S.A.
James Cooper is Professor of Law, Associate Dean of Experiential Learning, and Director of International Legal Studies at California Western School of Law in San Diego, California.
Professor Cooper has been a change agent for countries around the Americas for more than two decades, consulting for the U.S. Departments of Justice and State, the Organization of American States, USAID, USPTO, the Inter-American Development Bank, the Bolivian President’s Office for the Constituent Assembly negotiations, Mexico’s Executive Branch (Los Pinos), Paraguay’s Congress, and a number of other international and regional aid organizations and technical cooperation agencies.
An Intellectual Property and trade scholar, he has served on the U.S. government delegation to WIPO. A Cambridge University-trained Barrister and Solicitor, Professor Cooper’s public policy work has been commissioned by the Konrad Adenauer Foundation and the Friedrich Ebert Foundation of Germany as well as the Inter-American Drug Abuse Control Commission of the Organization of American States.
Professor Cooper has served as an academic staff member of the Heidelberg Center for Latin America Visiting Professor at University of California, San Diego, Justus Liebig University in Giessen, Germany, and the University of Macau. He contributes to newspapers, website platforms, television and radio news programs around the world. Professor Cooper is a member of the Protocol Braintrust.
1. James M. Cooper, Traditional Knowledge in Taiwan: A Call for Greater Participation of Indigenous Peoples in the Global Intellectual Property Marketplace
53 Vanderbilt J. Transnat’l L. 1477 (2020)
2. James Cooper, Is telemedicine the de-evolution of medicine?The Hill (Apr. 20, 2021)with Dr. Richard Weinstein, Dr. Jaspreet Rayat, & Dr. Toby Chan 3. James Cooper, We need to relax intellectual property rules to fight this virus,The Hill, (Apr. 6, 2020),with Bashar Malkawi 4. James Cooper, Telemedicine in the Time of Coronavirus,The Hill, (Apr. 6, 2020),with Dr. Tokio Matsuzaki
Dr. Kendrick Co Shih
Director of Student Affairs, LKS Faculty of Medicine, University of Hong Kong
Clinical Assistant Professor, Department of Ophthalmology, LKS Faculty of Medicine, University of Hong Kong
Dr. Kendrick Shih is the Director of Student Affairs and a Clinical Assistant Professor of Ophthalmology at the University of Hong Kong Li Ka Shing Faculty of Medicine.
His research interests are in the management of sight-threatening ocular surface diseases and in ophthalmic healthcare service enhancement.
During the COVID-19 pandemic, Kendrick, in his role as director, worked to develop new ways to effectively deliver tele-teaching in medical education and learner wellbeing during the COVID-19 pandemic.
1. Use of Gene Therapy in Retinal Ganglion Cell Neuroprotection: Current Concepts and Future Directions.Rhee J, Shih KC.Biomolecules. 2021 Apr 15;11(4):581. doi: 10.3390/biom11040581.PMID: 33920974 Free PMC article. Review. 2. Ophthalmological Considerations for COVID-19 Vaccination in Patients with Inflammatory Eye Diseases and Autoimmune Disorders.Chau CYC, Chow LLW, Sridhar S, Shih KC.Ophthalmol Ther. 2021 Jun;10(2):201-209. doi: 10.1007/s40123-021-00338-1. Epub 2021 Mar 6.PMID: 33675508 Free PMC article. 3. Aerosolization and Fluid Spillage During Phacoemulsification in Human Subjects.Wong JKW, Kwok JSWJ, Chan JCH, Shih KC, Qin R, Lau D, Lai JSM.Clin Ophthalmol. 2021 Jan 27;15:307-313. doi: 10.2147/OPTH.S294778. eCollection 2021.PMID: 33536739 Free PMC article. 4. Clinical skills education at the bed-side, web-side and lab-side.Tsang ACO, Shih KC, Chen JY.Med Educ. 2021 Jan;55(1):112-114. doi: 10.1111/medu.14394. Epub 2020 Oct 24.PMID: 33047370 No abstract available. 5. Sociodemographic, behavioral, and medical risk factors associated with visual impairment among older adults: a community-based pilot survey in Southern District of Hong Kong.Wong PW, Lau JK, Choy BN, Shih KC, Ng AL, Wong IY, Chan JC.BMC Ophthalmol. 2020 Sep 18;20(1):372. doi: 10.1186/s12886-020-01644-1.PMID: 32948134 Free PMC article. 6. Does the COVID-19 Pandemic Spell the End for the Direct Ophthalmoscope?Shih KC, Chau CYC, Chan JCH, Wong JKW, Lai JSM.Ophthalmol Ther. 2020 Dec;9(4):689-692. doi: 10.1007/s40123-020-00295-1. Epub 2020 Aug 29.PMID: 32860621 Free PMC article. 7. Epidemiological factors associated with health knowledge of three common eye diseases: A community-based pilot survey in Hong Kong.Wong PW, Lau JK, Choy BN, Shih KC, Ng AL, Chan JC, Wong IY.SAGE Open Med. 2020 Jul 20;8:2050312120943044. doi: 10.1177/2050312120943044. eCollection 2020.PMID: 32733677 Free PMC article. 8. Tele-ophthalmology amid COVID-19 pandemic-Hong Kong experience.Wong JKW, Shih KC, Chan JCH, Lai JSM.Graefes Arch Clin Exp Ophthalmol. 2021 Jun;259(6):1663. doi: 10.1007/s00417-020-04753-1. Epub 2020 May 29.PMID: 32472202 Free PMC article. No abstract available. 9. Ophthalmic clinical skills teaching in the time of COVID-19: A crisis and opportunity.Shih KC, Chan JC, Chen JY, Lai JS.Med Educ. 2020 Jul;54(7):663-664. doi: 10.1111/medu.14189. Epub 2020 May 23.PMID: 32324929 Free PMC article. No abstract available. 10. Diabetic retinopathy screening during the coronavirus disease 2019 pandemic.Shih KC, Kwong ASK, Wang JHL, Wong JKW, Ko WWK, Lai JSM, Chan JCH.Eye (Lond). 2020 Jul;34(7):1246-1247. doi: 10.1038/s41433-020-0928-7. Epub 2020 May 4.PMID: 32367007 Free PMC article. No abstract available.
Dr. Steven C. Cramer
Professor of Neurology at the University of California, Los Angeles, U.S.A.
Medical Director of Research at California Rehabilitation Institute, U.S.A.
Dr. Steven C. Cramer is a Professor of Neurology at the University of California, Los Angeles. He is also the Director of Research at California Rehabilitation Institute, co-PI of the NIH StrokeNet clinical trials network, and a Section Editor at the journal Stroke. Dr. Cramer graduated with Highest Honors from University of California, Berkeley; received his medical degree from University of Southern California; did a residency in internal medicine at UCLA; and did a residency in neurology plus a fellowship in cerebrovascular disease at Massachusetts General Hospital. He also earned a Masters Degree in Clinical Investigation from Harvard Medical School.
His research focuses on neural repair after central nervous system injury in humans, with an emphasis on stroke and on recovery of movement. Treatments examined include robotics, cellular therapies, a monoclonal antibody, brain stimulation, drugs, and telehealth methods. A major emphasis is on translating new drugs and devices to reduce disability after stroke, and on developing biomarkers to individualize therapy for each person’s needs. Dr. Cramer has been awarded the Stroke Rehabilitation Award from the American Heart Association, the Barbro B. Johansson Award in Stroke Recovery from the World Stroke Organization, the Award for Excellence in Post-Acute Stroke Rehabilitation from the American Congress of Rehabilitation Medicine, and he is the Susan and David Wilstein Endowed Chair in Rehabilitation Medicine. He also co-edited the book “Brain Repair after Stroke”, and is the author of over 300 manuscripts.